The clinically-pedigreed heavyweight. A stabilised GHRH analogue with regulatory approval in HIV-associated lipodystrophy and active hepatic and cognitive research. Research use only.
The clinically-pedigreed heavyweight of the GHRH category — Tesamorelin is one of the very few research peptides with active regulatory approval as a medicine, and it has one of the deepest clinical datasets in the entire secretagogue space.
Tesamorelin is a stabilised version of the full 44-amino-acid GHRH sequence, with a trans-3-hexenoic acid modification at the N-terminus that boosts resistance to enzymatic breakdown. It engages the GHRH receptor on pituitary somatotrophs, producing more sustained receptor activation than shorter or unmodified GHRH fragments while preserving the natural pulsatile release pattern.
Tesamorelin has the strongest clinical evidence base of any GHRH analogue currently studied, with regulatory authorisation in a specific HIV-related indication and active ongoing research in hepatic and cognitive contexts.
Visceral adipose tissue: Clinical trials reported reductions in visceral fat in HIV-associated lipodystrophy cohorts — the indication for which it received regulatory approval.
GH and IGF-1 dynamics: Sustained IGF-1 elevation within physiological ranges.
Cognitive research: Studies examining cognitive performance in older adults and mild cognitive impairment cohorts.
NAFLD research: Investigation in non-alcoholic fatty liver disease with reported reductions in hepatic fat fraction.
This landmark multi-center human trial evaluated Tesamorelin's ability to selectively eliminate dangerous, deep-belly fat (visceral adipose tissue) and reverse severe metabolic complications.
As Seen In The Press
Peptides can affect the way the body functions at a cellular level.
Pre-filled Cartridges
Engineered for absolute accuracy and ease. Our pre-blended pens make precise dosing completely seamless in just three quick steps.
Step 1 - Remove the Pre-mixed pen from the box
Step 2 - Secure the needle tip
Step 3 - Twist to set the required dose
Blends
The flagship triple combination of modern mitochondrial research. SS-31, MOTS-c, and NAD+ each act on a different layer of cellular energy biology — structure,. Research use only.
£159.99
Blends
The most famous tissue repair stack in research. BPC-157 brings angiogenesis and gastrointestinal protection; TB-500 brings cytoskeletal regulation and cell migration. Two of the. Research use only.
£102.99
Blends
The Wolverine stack, levelled up. Adding GHK-Cu — the most extensively studied dermal and tissue repair peptide on the market — brings extracellular matrix. Research use only.
£101.99
